The advent of cannabis as a viable U.S. industry has created the need for supportable and objective valuations, especially for merger and acquisition work. But rendering a supportable valuation opinion for cannabis companies is particularly challenging
Veranstaltungsart: CLE / CPD, Webinar
- Startdatum / -uhrzeit:
- 7 November 2019, 12:00 PM ET
- Enddatum / -uhrzeit:
- 7 November 2019, 1:00 PM ET
Complicating factors include:
- The regulatory and legal framework for cannabis companies and the impact to financial projections
- Complex tax, banking and securities issues
- Lack of empirical data for valuations in this emerging industry
- Intellectual property enforcement issues that uniquely impact valuations in the cannabis industry
Join us for an overview of the complicated issues facing cannabis company transactions.